Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
May 29  •  04:00PM ET
5.28
Dollar change
-0.19
Percentage change
-3.47
%
Index
-
P/E
-
EPS (ttm)
-1.06
Insider Own
1.82%
Shs Outstand
5.19M
Perf Week
-4.00%
Market Cap
27.40M
Forward P/E
-
EPS next Y
-
Insider Trans
-68.38%
Shs Float
5.09M
Perf Month
-22.47%
Enterprise Value
104.97M
PEG
-
EPS next Q
-
Inst Own
1.21%
Perf Quarter
-33.25%
Income
-9.23M
P/S
0.02
EPS this Y
-
Inst Trans
-56.61%
Perf Half Y
50.86%
Sales
1.75B
P/B
-
EPS next Y
-
ROA
-2.65%
Perf YTD
106.25%
Book/sh
-11.44
P/C
0.31
EPS next 5Y
-
ROE
-
52W High
11.17 -52.73%
Perf Year
-36.00%
Cash/sh
16.86
P/FCF
-
EPS past 3/5Y
47.72% 33.28%
ROIC
-
52W Low
2.48 112.90%
Perf 3Y
-79.21%
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
-4.53% 8.01%
Gross Margin
5.76%
Volatility
13.26% 9.47%
Perf 5Y
-94.57%
Dividend TTM
-
EV/Sales
0.06
EPS Y/Y TTM
-1.34%
Oper. Margin
-0.08%
ATR (14)
0.49
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
0.57
Sales Y/Y TTM
-12.80%
Profit Margin
-0.53%
RSI (14)
36.22
Dividend Gr. 3/5Y
- -
Current Ratio
1.09
EPS Q/Q
18.28%
SMA20
-7.97%
Beta
0.62
Payout
-
Debt/Eq
-
Sales Q/Q
-25.69%
SMA50
-15.57%
Rel Volume
1.36
Prev Close
5.47
Employees
1063
LT Debt/Eq
-
SMA200
-4.25%
Avg Volume
14.14K
Price
5.28
IPO
Sep 12, 2018
Option/Short
No / Yes
Trades
Volume
19,167
Change
-3.47%
Date Action Analyst Rating Change Price Target Change
Apr-15-21Resumed Citigroup Buy $16
Apr-09-26 03:00AM
Dec-17-25 01:00AM
Sep-17-25 02:00AM
Jun-19-25 03:03AM
Apr-21-25 04:29PM
03:03PM Loading…
Mar-20-25 03:03PM
01:00AM
Mar-12-25 07:00AM
Feb-20-25 05:00AM
Feb-11-25 08:00AM
Jan-08-25 05:00AM
Nov-28-24 06:33AM
02:01AM
Nov-27-24 05:02AM
01:00AM
05:00AM Loading…
Nov-21-24 05:00AM
Nov-04-24 06:00AM
05:00AM
Oct-22-24 05:10AM
Oct-18-24 05:00AM
Oct-10-24 06:02AM
Sep-27-24 05:00PM
Sep-13-24 07:30AM
Aug-29-24 02:00AM
Aug-27-24 08:00AM
Jul-29-24 01:00AM
Jul-19-24 08:45AM
Jul-17-24 01:31AM
Jun-11-24 03:57AM
May-23-24 08:52AM
04:43AM Loading…
04:43AM
Apr-30-24 02:30AM
Mar-22-24 11:36AM
Mar-21-24 04:47AM
Mar-01-24 04:00AM
Feb-27-24 08:58AM
Dec-01-23 09:20AM
Nov-30-23 01:00AM
Nov-13-23 12:10AM
Aug-31-23 08:09AM
Aug-24-23 02:00AM
Jul-31-23 05:59AM
Jun-15-23 05:03AM
01:15AM
May-25-23 02:05AM
Mar-27-23 06:26AM
Mar-23-23 05:07AM
02:17AM
Mar-02-23 02:35AM
Feb-16-23 12:33AM
Dec-01-22 02:33AM
Nov-08-22 01:09AM
Sep-23-22 12:30AM
Sep-09-22 05:53AM
Aug-25-22 02:18AM
Aug-08-22 01:19PM
Aug-05-22 02:26AM
Jun-16-22 03:58AM
May-26-22 04:59AM
May-05-22 01:46PM
05:18AM
Apr-13-22 05:02AM
Mar-17-22 03:20AM
Mar-14-22 07:35AM
Mar-04-22 04:24AM
Mar-01-22 08:55AM
Feb-22-22 03:38AM
Jan-03-22 09:38PM
Nov-22-21 12:14PM
Nov-19-21 12:31AM
Nov-01-21 04:57PM
Oct-28-21 07:00PM
Oct-25-21 07:00AM
Sep-17-21 07:00AM
Sep-07-21 05:00AM
Aug-27-21 02:30AM
Aug-16-21 08:00AM
Aug-13-21 07:16AM
Aug-09-21 07:30AM
Aug-03-21 08:00AM
Jun-18-21 10:09AM
May-19-21 02:17AM
May-12-21 10:10AM
Apr-21-21 08:00AM
Mar-25-21 05:00AM
Mar-18-21 06:10AM
Mar-17-21 06:50AM
Mar-16-21 05:40AM
Feb-05-21 06:00AM
Jan-01-21 03:24AM
Dec-22-20 04:22AM
Nov-29-20 11:42AM
Nov-19-20 05:00AM
Oct-22-20 06:00AM
Oct-19-20 06:50AM
Oct-15-20 05:40PM
05:35PM
05:30PM
Sep-30-20 06:00AM
Sep-23-20 12:53PM
111, Inc. Is a holding company, which engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.
Co-Founder & Executive ChairmanDr. Gang Yu Ph.D.
Co-FounderMr. Junling Liu
IR DirectorMonica Mu
Chief Innovation OfficerMr. Anfeng Guo
Finance DirectorMr. Alex Liu
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Luo Jun JustinDirectorMay 27 '26Sale0.2570,44017,610710,551May 29 08:51 AM
Luo Jun JustinDirectorMay 26 '26Sale0.2729,2807,906780,991May 29 08:51 AM
Sun Jian DavidDirectorMay 27 '26Sale0.2570,44017,610710,551May 29 08:48 AM
Sun Jian DavidDirectorMay 26 '26Sale0.2729,2807,906780,991May 29 08:48 AM
Chen Yang LukeDirectorMay 27 '26Sale0.253,400850589,382May 29 08:46 AM
Chen Yang LukeDirectorMay 26 '26Sale0.271,440389592,782May 29 08:46 AM
Last Close
May 29  •  04:00PM ET
90.98
Dollar change
-1.99
Percentage change
-2.14
%
CVS CVS Health Corp daily Stock Chart
Index
S&P 500
P/E
39.95
EPS (ttm)
2.28
Insider Own
0.16%
Shs Outstand
1.28B
Perf Week
-2.51%
Market Cap
116.08B
Forward P/E
10.87
EPS next Y
8.37
Insider Trans
-62.77%
Shs Float
1.27B
Perf Month
8.44%
Enterprise Value
182.79B
PEG
0.87
EPS next Q
1.83
Inst Own
89.28%
Perf Quarter
13.87%
Income
2.93B
P/S
0.28
EPS this Y
9.41%
Inst Trans
-1.32%
Perf Half Y
15.94%
Sales
407.94B
P/B
1.50
EPS next Y
13.33%
ROA
1.15%
Perf YTD
14.64%
Book/sh
60.85
P/C
9.82
EPS next 5Y
12.56%
ROE
3.80%
52W High
98.43 -7.57%
Perf Year
44.92%
Cash/sh
9.26
P/FCF
15.70
EPS past 3/5Y
-24.70% -23.94%
ROIC
1.94%
52W Low
58.50 55.52%
Perf 3Y
34.51%
EV/EBITDA
10.23
Sales past 3/5Y
7.60% 8.40%
Gross Margin
13.88%
Volatility
2.33% 2.52%
Perf 5Y
5.25%
EV/Sales
0.45
EPS Y/Y TTM
-45.09%
Oper. Margin
3.26%
ATR (14)
2.34
Perf 10Y
-6.15%
Quick Ratio
0.66
Sales Y/Y TTM
7.68%
Profit Margin
0.72%
RSI (14)
55.66
Current Ratio
0.87
EPS Q/Q
63.49%
SMA20
-0.29%
Beta
0.63
Debt/Eq
1.01
Sales Q/Q
6.17%
SMA50
10.93%
Rel Volume
1.22
Prev Close
92.97
Employees
300000
LT Debt/Eq
0.95
SMA200
16.06%
Avg Volume
7.99M
Price
90.98
IPO
Oct 01, 1952
Option/Short
Yes / Yes
Trades
Volume
9,718,045
Change
-2.14%
Date Action Analyst Rating Change Price Target Change
Mar-12-26Upgrade Bernstein Mkt Perform → Outperform $94
Oct-14-25Initiated Goldman Buy $91
Aug-18-25Upgrade UBS Neutral → Buy $79
Aug-14-25Upgrade Robert W. Baird Neutral → Outperform $82
Feb-13-25Upgrade Leerink Partners Market Perform → Outperform $55 → $75
Feb-12-25Upgrade Cantor Fitzgerald Neutral → Overweight
Jan-30-25Upgrade Edward Jones Hold → Buy
Dec-03-24Upgrade Deutsche Bank Hold → Buy $66
Nov-18-24Upgrade Wells Fargo Equal Weight → Overweight $60 → $66
Oct-10-24Upgrade Barclays Equal Weight → Overweight $63 → $82
May-29-26 10:22AM
08:00AM
May-28-26 06:14PM
06:07PM
04:01PM
03:41PM Loading…
03:41PM
03:08PM
02:08PM
02:07PM
01:55PM
12:54PM
12:37PM
08:50AM
07:30AM
07:30AM
07:20AM Loading…
07:20AM
07:09AM
06:49AM
06:45AM
May-27-26 07:14AM
05:10AM
May-26-26 09:00AM
May-22-26 05:54PM
05:00AM
May-21-26 04:15PM
03:19PM
09:00AM
May-20-26 03:47PM
08:30AM
07:15AM
03:50PM Loading…
May-19-26 03:50PM
May-18-26 08:30AM
08:17AM
May-14-26 08:00AM
01:30AM
May-13-26 04:00PM
08:00AM
May-12-26 06:02AM
May-07-26 10:19AM
08:17AM
May-06-26 11:48AM
11:06AM
08:15AM
08:15AM
08:12AM
07:14AM
06:36AM
06:30AM
06:30AM
05:27AM
May-05-26 08:00AM
May-02-26 09:16PM
May-01-26 07:56PM
Apr-30-26 03:03PM
01:00PM
03:00AM
Apr-28-26 02:29PM
11:45AM
08:00AM
Apr-27-26 04:00PM
Apr-24-26 08:20AM
07:36AM
07:30AM
Apr-22-26 10:13AM
12:01AM
Apr-21-26 01:54PM
09:36AM
09:17AM
07:23AM
06:40AM
Apr-08-26 05:01PM
10:18AM
06:30AM
05:10AM
Apr-07-26 06:13PM
02:57PM
02:23PM
12:24PM
12:17PM
11:15AM
11:04AM
10:40AM
10:16AM
08:57AM
07:52AM
06:39AM
06:04AM
05:56AM
04:36AM
03:26AM
Apr-06-26 05:51PM
05:47PM
04:58PM
09:00AM
Apr-01-26 03:07PM
Mar-31-26 05:23AM
Mar-30-26 08:01PM
01:33PM
12:00PM
Mar-29-26 10:29AM
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
CEOMr. J. David Joyner CEBS
Executive VP & CFOMr. Brian O. Newman
EVP of Ventures and Chief Experience & Technology OfficerMr. Tilak Mandadi
Executive VP & Group PresidentMr. Prem S. Shah Pharm.D
Executive VP & President of AetnaMr. Steven Hale Nelson M.B.A.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
AGUIRRE FERNANDODirectorMay 20 '26Proposed Sale94.692,263214,283May 22 05:35 PM
ROBBINS LARRYDirectorMay 19 '26Sale94.451,983,538187,341,3086,213,261May 21 05:43 PM
ROBBINS LARRYDirectorMay 20 '26Sale93.821,018,00095,510,8225,195,261May 21 05:43 PM
ROBBINS LARRYDirectorMay 21 '26Sale93.45370,46234,619,0074,824,799May 21 05:43 PM
FARAH ROGER NDirectorMay 21 '26Proposed Sale93.682,817263,886May 21 12:57 PM
Mandadi TilakEVP, Chief Exp & Tech OfficerMay 08 '26Sale89.5869,5516,230,37910,133May 11 05:27 PM
TILAK MANDADIOfficerMay 08 '26Proposed Sale89.5869,5516,230,719May 08 04:36 PM
Finucane Anne A.DirectorAug 20 '25Sale71.027,500532,65022,156Aug 29 04:29 PM
Finucane Anne A.DirectorAug 20 '25Proposed Sale70.977,500532,275Aug 19 06:57 PM
SANSONE GUY PDirectorJun 05 '25Buy63.701,570100,00912,007Jun 09 08:22 AM
Last Close
May 29  •  04:00PM ET
38.74
Dollar change
-0.01
Percentage change
-0.03
%
GRDN Guardian Pharmacy Services Inc daily Stock Chart
Index
RUT
P/E
46.38
EPS (ttm)
0.84
Insider Own
61.83%
Shs Outstand
49.78M
Perf Week
0.96%
Market Cap
2.45B
Forward P/E
28.52
EPS next Y
1.36
Insider Trans
-26.51%
Shs Float
24.17M
Perf Month
3.11%
Enterprise Value
2.44B
PEG
2.36
EPS next Q
0.26
Inst Own
44.89%
Perf Quarter
15.61%
Income
53.07M
P/S
1.68
EPS this Y
17.76%
Inst Trans
21.26%
Perf Half Y
31.95%
Sales
1.46B
P/B
11.11
EPS next Y
7.80%
ROA
13.95%
Perf YTD
28.75%
Book/sh
3.49
P/C
37.80
EPS next 5Y
12.08%
ROE
28.15%
52W High
41.36 -6.33%
Perf Year
81.11%
Cash/sh
1.02
P/FCF
35.04
EPS past 3/5Y
10.88% 31.17%
ROIC
21.18%
52W Low
19.17 102.09%
Perf 3Y
-
Dividend Est.
-
EV/EBITDA
22.83
Sales past 3/5Y
16.81% 16.29%
Gross Margin
20.93%
Volatility
3.50% 4.44%
Perf 5Y
-
Dividend TTM
-
EV/Sales
1.67
EPS Y/Y TTM
159.50%
Oper. Margin
5.75%
ATR (14)
1.52
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
1.17
Sales Y/Y TTM
13.54%
Profit Margin
3.64%
RSI (14)
60.61
Dividend Gr. 3/5Y
- -
Current Ratio
1.46
EPS Q/Q
38.95%
SMA20
4.55%
Beta
0.08
Payout
0.00%
Debt/Eq
0.17
Sales Q/Q
2.21%
SMA50
3.96%
Rel Volume
1.23
Prev Close
38.75
Employees
3600
LT Debt/Eq
0.13
SMA200
24.04%
Avg Volume
479.11K
Price
38.74
IPO
Sep 26, 2024
Option/Short
Yes / Yes
Trades
Volume
591,536
Change
-0.03%
Date Action Analyst Rating Change Price Target Change
Apr-27-26Initiated BofA Securities Buy $42
Mar-30-26Initiated Jefferies Buy $44
Oct-10-25Initiated Oppenheimer Outperform $30
Oct-21-24Initiated Truist Buy $22
Oct-21-24Initiated Raymond James Outperform $21
May-07-26 08:30AM
May-06-26 05:38PM
04:05PM
Apr-23-26 05:00PM
Apr-14-26 04:30PM
06:10AM Loading…
Mar-19-26 06:10AM
Mar-18-26 04:20PM
Mar-11-26 11:01PM
08:12PM
04:29PM
04:05PM
Mar-10-26 04:30PM
09:18AM
Mar-09-26 07:10AM
Mar-05-26 12:00PM
04:30PM Loading…
Feb-12-26 04:30PM
Feb-09-26 04:30PM
Jan-25-26 08:22PM
Jan-13-26 04:30PM
Jan-07-26 03:39PM
Dec-15-25 04:30PM
Nov-17-25 11:29AM
Nov-12-25 11:18AM
Nov-11-25 03:24PM
12:02AM
Nov-10-25 05:20PM
04:20PM
04:05PM
Nov-07-25 07:18AM
Nov-05-25 05:45PM
08:45AM Loading…
Nov-04-25 08:45AM
Nov-03-25 10:00AM
Oct-30-25 08:30AM
Oct-28-25 04:30PM
Oct-14-25 04:47PM
Oct-06-25 08:30AM
Sep-12-25 08:57AM
Sep-11-25 08:30AM
Sep-01-25 09:55AM
Aug-25-25 12:00PM
Aug-11-25 06:10PM
04:05PM
Aug-04-25 08:07AM
Jul-23-25 08:28AM
Jul-22-25 04:05PM
Jun-10-25 10:03AM
Jun-02-25 08:07AM
May-22-25 11:15PM
May-20-25 04:16PM
May-14-25 10:03AM
May-13-25 03:09AM
May-12-25 04:23PM
04:05PM
May-08-25 04:05PM
Apr-30-25 04:12PM
Apr-14-25 10:03AM
Apr-08-25 10:03AM
Mar-27-25 06:32AM
03:02AM
Mar-26-25 04:18PM
04:01PM
Mar-22-25 11:00AM
Mar-03-25 06:00AM
Feb-17-25 04:05PM
Dec-17-24 09:00AM
Nov-12-24 04:41PM
04:05PM
Oct-31-24 08:00AM
Oct-30-24 08:00AM
Oct-21-24 02:54PM
Oct-08-24 09:02AM
Sep-26-24 10:50AM
Sep-25-24 09:45PM
09:10PM
Guardian Pharmacy Services, Inc. engages in the provision of client service and resident care to long-term care communities. It offers assisted living and skilled nursing, group homes, behavioral health and organizations that serve individuals with intellectual and developmental disabilities. The company was founded by Fred Burke, David Morris, and Kendall Forbes on July 21, 2003 and is headquartered in Atlanta, GA.
CEOMr. Fred P. Burke
CFOMr. David K. Morris
Executive Vice President of Sales & OperationsMr. Kendall Forbes R.Ph.
Senior VP of TechnologyMr. David Martin
Head of Investor Relations & Senior DirectorMs. Ashley Stockton
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Pharmacy Investors, LLCMember of 10% owner groupMar 20 '26Sale29.68827,63624,566,3061,035,928Mar 24 04:15 PM
Morris David KSee RemarksMar 20 '26Sale29.68187,8555,576,006254,472Mar 24 04:15 PM
Burke FredSee RemarksMar 20 '26Sale29.68671,43219,929,780840,413Mar 24 04:15 PM
Forbes KendallSee RemarksMar 20 '26Sale29.68346,67210,290,092453,256Mar 24 04:15 PM
Cardinal Equity Fund, L.P.Member of 10% owner groupMar 20 '26Sale29.68275,7288,184,296345,123Mar 24 04:15 PM
Salentine Thomas J JrDirectorMar 20 '26Sale29.683,570,677105,986,6204,469,316Mar 24 04:15 PM
Bindley Capital Partners I, LL10% OwnerMar 20 '26Sale29.683,570,677105,986,6204,469,316Mar 24 04:15 PM
Ackerman JohnDirectorMar 20 '26Sale29.681,103,36432,750,602345,123Mar 24 04:15 PM
BINDLEY WILLIAM EDirectorMar 20 '26Sale29.683,570,677105,986,6204,469,316Mar 24 04:15 PM
COSLER STEVEN DDirectorDec 03 '25Buy29.613,37099,78624,984Dec 05 04:10 PM
Last Close
May 29  •  04:00PM ET
2.17
Dollar change
-0.03
Percentage change
-1.36
%
PETS Petmed Express Inc daily Stock Chart
Index
-
P/E
-
EPS (ttm)
-3.12
Insider Own
31.17%
Shs Outstand
21.38M
Perf Week
0.00%
Market Cap
46.44M
Forward P/E
31.00
EPS next Y
0.07
Insider Trans
0.00%
Shs Float
14.73M
Perf Month
-3.98%
Enterprise Value
20.19M
PEG
-
EPS next Q
-0.18
Inst Own
28.19%
Perf Quarter
-20.80%
Income
-64.87M
P/S
0.25
EPS this Y
-1033.33%
Inst Trans
-4.00%
Perf Half Y
33.13%
Sales
182.67M
P/B
1.42
EPS next Y
102.57%
ROA
-55.74%
Perf YTD
-32.19%
Book/sh
1.53
P/C
1.73
EPS next 5Y
-
ROE
-100.61%
52W High
4.32 -49.77%
Perf Year
-42.59%
Cash/sh
1.26
P/FCF
-
EPS past 3/5Y
- -
ROIC
-196.97%
52W Low
1.57 38.22%
Perf 3Y
-85.41%
EV/EBITDA
-
Sales past 3/5Y
-6.02% -4.39%
Gross Margin
25.28%
Volatility
5.67% 4.20%
Perf 5Y
-92.49%
EV/Sales
0.11
EPS Y/Y TTM
-19236.81%
Oper. Margin
-15.90%
ATR (14)
0.10
Perf 10Y
-88.54%
Quick Ratio
0.66
Sales Y/Y TTM
-26.05%
Profit Margin
-35.51%
RSI (14)
42.39
Current Ratio
0.89
EPS Q/Q
-1364.43%
SMA20
-3.15%
Beta
0.79
Debt/Eq
0.02
Sales Q/Q
-23.26%
SMA50
-4.93%
Rel Volume
1.54
Prev Close
2.20
Employees
173
LT Debt/Eq
0.01
SMA200
-18.05%
Avg Volume
88.72K
Price
2.17
IPO
Apr 26, 1999
Option/Short
Yes / Yes
Trades
Volume
136,267
Change
-1.36%
Date Action Analyst Rating Change Price Target Change
May-25-23Initiated Lake Street Buy $20
Jan-20-22Upgrade Sidoti Neutral → Buy $32
Nov-18-21Initiated Morgan Stanley Underweight $25
Oct-01-21Initiated Jefferies Hold $28
Aug-05-21Resumed Credit Suisse Underperform $22
Jun-03-21Downgrade Sidoti Buy → Neutral $39
Mar-05-21Upgrade Sidoti Neutral → Buy
Jan-27-21Downgrade Sidoti Buy → Neutral
Aug-19-20Upgrade Sidoti Neutral → Buy $37 → $41
Apr-09-20Downgrade Sidoti Buy → Neutral
May-29-26 08:00AM
Apr-22-26 04:05PM
Dec-19-25 05:02PM
Dec-16-25 12:04PM
Dec-11-25 09:45AM
08:00AM Loading…
Dec-10-25 08:00AM
Nov-26-25 04:05PM
Nov-13-25 08:00AM
Oct-27-25 05:30PM
Oct-20-25 08:30AM
Oct-14-25 04:15PM
Oct-10-25 08:38AM
Oct-08-25 04:05PM
Sep-25-25 12:05PM
Sep-10-25 08:25AM
07:45AM Loading…
Aug-25-25 07:45AM
Aug-15-25 05:59AM
Aug-12-25 04:11PM
Aug-08-25 08:30AM
Jul-30-25 08:15AM
Jul-23-25 08:00AM
Jul-03-25 08:30AM
Jul-01-25 08:30AM
Jun-24-25 09:00AM
Jun-16-25 08:30AM
Jun-10-25 06:02PM
04:05PM
07:30AM
Jun-09-25 09:16AM
May-27-25 04:05PM
08:10AM Loading…
08:10AM
May-07-25 09:08AM
Apr-11-25 09:00AM
Apr-09-25 08:00AM
Mar-07-25 04:30AM
Feb-11-25 07:05AM
02:05AM
Feb-10-25 04:16PM
04:05PM
Feb-07-25 07:09AM
Jan-30-25 04:05PM
Jan-07-25 08:00AM
Dec-23-24 09:50AM
Dec-05-24 09:50AM
Dec-03-24 08:30AM
Nov-30-24 07:19PM
Nov-14-24 10:00AM
09:50AM
Nov-07-24 04:05PM
02:20AM
Nov-06-24 04:48PM
04:05PM
Nov-05-24 08:08AM
Oct-24-24 02:46PM
08:00AM
Oct-09-24 09:50AM
Sep-27-24 04:17PM
Sep-23-24 09:50AM
Sep-12-24 08:00AM
Aug-21-24 08:30AM
Aug-07-24 12:45PM
Aug-06-24 05:41PM
04:05PM
Aug-05-24 04:05PM
Jul-23-24 08:00AM
Jun-27-24 01:36PM
01:36PM
Jun-24-24 08:00AM
Jun-16-24 07:00AM
Jun-12-24 08:02AM
03:52AM
Jun-11-24 08:53PM
04:25PM
04:05PM
Jun-03-24 08:00AM
May-28-24 08:00AM
May-22-24 04:05PM
May-20-24 08:00AM
Apr-30-24 08:34AM
Apr-29-24 10:25AM
08:15AM
Apr-15-24 12:52PM
08:26AM
08:16AM
Apr-04-24 01:45PM
Mar-18-24 03:44AM
Mar-13-24 08:17AM
Feb-28-24 06:00PM
Feb-22-24 04:21AM
Feb-16-24 08:30AM
Feb-15-24 01:34PM
08:30AM
Feb-14-24 01:47AM
Feb-09-24 09:26AM
06:05AM
Feb-08-24 04:56PM
04:01PM
Jan-29-24 08:30AM
Jan-08-24 05:46PM
Dec-19-23 06:36PM
PetMed Express, Inc. markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. The firm provides treatments for allergies, arthritis, anxiety, dermatitis, diabetes, and heartworms. It offers access to a range of non-prescription health and wellness products and Rx food, non-Rx food, and treats. The company was founded in January 1996 and is headquartered in Delray Beach, FL.
Executive Chairman of the BoardMs. Leslie C. G. Campbell
Chief Accounting OfficerMr. Douglas Krulik
Chief Operating OfficerMs. Caroline Conegliano
Corporate Secretary & General CounselMr. Robert Lawsky
Vice President of PeopleMs. Jacqueline Smith
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Silvercape Investments Ltd10% OwnerAug 13 '25Buy3.17101,000320,1702,579,696Aug 14 08:40 AM
Silvercape Investments Ltd10% OwnerAug 01 '25Buy3.21118,200379,4222,478,696Aug 04 08:26 AM
NINA CAPITAL HOLDINGS INC.10% OwnerJul 21 '25Buy3.5025,00087,4252,575,000Jul 22 04:15 PM
Silvercape Investments Ltd10% OwnerJul 18 '25Buy3.2317,56556,7352,360,496Jul 21 08:13 AM
Silvercape Investments Ltd10% OwnerJul 17 '25Buy3.1531,70199,8582,342,931Jul 18 06:02 AM
Silvercape Investments Ltd10% OwnerJul 02 '25Buy3.222,8179,0712,311,230Jul 03 10:19 AM
Silvercape Investments Ltd10% OwnerJul 01 '25Buy3.216942,2282,308,413Jul 02 02:41 PM
NINA CAPITAL HOLDINGS INC.10% OwnerJun 03 '25Buy3.9425,00098,3752,550,000Jun 04 04:15 PM